Journal of AdvancedMedical and Dental Sciences Research

Dysgeusia is that the first recognized oral symptom of novel coronavirus disease (COVID-19). during this review , we described oral lesions of COVID-19 patients. We searched PubMed library and Google Scholar for published .Finally, we selected few articles including case reports, case series and letters to editor. Oral manifestations included ulcer, erosion, bulla, vesicle, pustule, fissured or depapillated tongue, macule, papule, plaque, pigmentation, halitosis, whitish areas, hemorrhagic crust, necrosis, petechiae, swelling, erythema, and spontaneous bleeding. the foremost common sites of involvement in descending order were tongue (38%), labial mucosa (26%), and palate (22%). Suggested diagnoses of the lesions were aphthous stomatitis, herpetiform lesions, candidiasis, vasculitis, Kawasaki-like, EM-like, mucositis, drug eruption, necrotizing periodontitis , angina bullosa-like, angular cheilitis, atypical Sweet syndrome, and Melkerson-Rosenthal syndrome. Oral lesions were symptomatic in 68% of the cases. Oral lesions were nearly equal in both genders (49% female and 51% male). Patients with older age and better severity of COVID-19 disease had more widespread and severe oral lesions. Lack of oral hygiene, opportunistic infections, stress, immunosuppression, vasculitis, and hyper-inflammatory response secondary to COVID-19 are the foremost important predisposing factors for onset of oral lesions in COVID-19 patients[1] There are increasing case reports of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19), especially in India. Oral manifestations also are seen in mucormycosis ,Diabetes mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. We aim to conduct a scientific review of literature to seek out out the patient's characteristics having mucormycosis and COVID-19.[6]